“…11 The prevalence of AD among children aged 15-17 years was 1.16%. 10,11 In a study of allergic diseases conducted in Russian adolescents, the prevalence of AD was shown to be up to 5-times greater than that reported in official statistics. 12 Alongside regional differences in the prevalence of AD, the progress and symptoms of AD can differ between races.…”
Section: Introductionmentioning
confidence: 90%
“…9 In Russia, data published between 2006 and 2016 reported that the incidence of AD was 6.2-15.5%, and was region dependent. 10,11 In 2016, 72% of all patients with AD were children (0-17 years old); 41% of these cases were among children aged 0-4 years. 11 The prevalence of AD among children aged 15-17 years was 1.16%.…”
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
“…11 The prevalence of AD among children aged 15-17 years was 1.16%. 10,11 In a study of allergic diseases conducted in Russian adolescents, the prevalence of AD was shown to be up to 5-times greater than that reported in official statistics. 12 Alongside regional differences in the prevalence of AD, the progress and symptoms of AD can differ between races.…”
Section: Introductionmentioning
confidence: 90%
“…9 In Russia, data published between 2006 and 2016 reported that the incidence of AD was 6.2-15.5%, and was region dependent. 10,11 In 2016, 72% of all patients with AD were children (0-17 years old); 41% of these cases were among children aged 0-4 years. 11 The prevalence of AD among children aged 15-17 years was 1.16%.…”
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Atopic dermatitis (AD) is a chronic inflammatory skin disease. Its crucial component of pathogenesis is malfunction of the epidermal barrier. Filaggrin protein and associated mutations in the filaggrin gene play one of the key roles in this problem. Nowadays new topical products (emollients) has been created and implemented into practice with the aim of more personalized approach and increased therapy efficacy in patients with AD. Such drugs would allow us to restore epidermal barrier function and to achieve elimination of disease symptoms.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.